ERNA: Eterna Therapeutics Inc. Stock

by  •  • Comments Off on ERNA: Eterna Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 27.05
Enterprise Value ($M) 59.75
Book Value ($M) -45.39
Book Value / Share -0.88
Price / Book -0.60
NCAV ($M) -48.38
NCAV / Share -0.94
Price / NCAV -0.56

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.86
Return on Equity (ROE) -12.61

Liquidity (mrq)
Quick Ratio 0.48
Current Ratio 0.48

Balance Sheet (mrq) ($M)
Current Assets 4.73
Assets 7.72
Liabilities 53.11
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-19 13G/A Singer Nicholas Jason 9.99 7.73
12-22 13D/A Cherington Charles 19.99 0.00
12-20 13G Iaf, Llc 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPOR
2024-03-18 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1)
2024-03-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-26 80,424 231,582 34.73
2024-11-25 142,539 939,303 15.17
2024-11-22 32,245 111,128 29.02
2024-11-21 25,799 313,473 8.23

(click for more detail)

Similar Companies
ENVB – Enveric Biosciences, Inc. EPIX – ESSA Pharma Inc.
EQ – Equillium, Inc. ESLA – Estrella Immunopharma, Inc.
EVOK – Evoke Pharma, Inc.


Financial data and stock pages provided by
Fintel.io